Physician profile
Benjamin G Romick
NPI 1497774434
$15,466.94
in general payments reported to CMS, 2019-2025
31 companies · $525 in 2025
The $525 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,865 · 2020: $363 · 2021: $679 · 2022: $2,101 · 2023: $1,789 · 2024: $2,145 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,865 · Travel and Lodging: $1,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,865.10 |
| Travel and Lodging | $1,593.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,772.48 | 2019-2020 | |
| Abbott Laboratories | $4,035.06 | 2019-2024 | Aveir, Ensite, Assurity |
| Medtronic, INC. | $2,291.78 | 2022-2025 | Resolute Onyx, Selectsecure, Symplicity G3 |
| Philips North America LLC | $653.74 | 2019-2025 | (9266) Elca, Coronary Other |
| Amgen INC. | $405.21 | 2019-2020 | |
| Biotronik INC. | $404.15 | 2019 | |
| Cardiovascular Systems INC. | $355.51 | 2019-2022 | |
| Heartflow, INC. | $291.92 | 2019 | |
| Acist Medical Systems, INC. | $254.00 | 2021 | |
| Boston Scientific Corporation | $227.11 | 2019-2025 | General - Brady, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.54 | 2019-2020 | |
| Abiomed | $185.38 | 2019-2024 | Impella |
| Janssen Pharmaceuticals, INC | $168.45 | 2019-2020 | |
| Shockwave Medical, INC | $158.56 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $119.67 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi-Aventis U.S. LLC | $107.11 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $92.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $91.29 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $85.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $76.96 | 2019 | |
| Chiesi USA, INC. | $58.10 | 2019-2020 | |
| Livanova USA, INC. | $41.21 | 2019 | |
| Amarin Pharma, INC. | $34.68 | 2019-2020 | |
| Irhythm Technologies, INC. | $31.07 | 2019-2020 | |
| Teleflex LLC | $28.78 | 2025 | Guideliner |
| Cathworks, INC. | $26.32 | 2020 | |
| Astellas Pharma US INC | $22.16 | 2020 | |
| Lundbeck LLC | $21.79 | 2019 | |
| Bardy Diagnostics, INC. | $20.97 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Romick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.